Comparison of physician practice patterns for older adults compared to NHANES diabetes cohort on oral/other therapy

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 13, Issue 1, 2013, Pages 153-160

  Shaya, Fadia T ^a,b   Chirikov, Viktor V ^a   Bron, Morgan ^c   Howard, Deleonardo ^a   Foster, Clyde ^a   Yan, Xia ^a   Khanna, Niharika ^b   Warrington, Verlyn O ^d  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c Takeda Pharmaceuticals International Inc   (United States)

^d UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

combination therapy; diabetes; elderly; monotherapy; NHANES; older adults; trends

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; AMYLIN DERIVATIVE; BIGUANIDE DERIVATIVE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLIBENCLAMIDE; GLIMEPIRIDE; GLIPIZIDE; GLITAZONE DERIVATIVE; HEMOGLOBIN A1C; INCRETIN; INSULIN; MEGLITINIDE; METFORMIN; PIOGLITAZONE; SULFONYLUREA DERIVATIVE;

ADULT; AGE; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; DRUG USE; ELDERLY CARE; FEMALE; GLYCEMIC CONTROL; HEALTH SURVEY; HEART INFARCTION; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MONOTHERAPY; NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; SELF REPORT; TREND STUDY;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGE FACTORS; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; DRUG UTILIZATION REVIEW; FEMALE; GUIDELINE ADHERENCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUTRITION SURVEYS; ODDS RATIO; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; RISK FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84873917545     PISSN: 14737167     EISSN: 17448379     Source Type: Journal    
DOI: 10.1586/erp.12.75     Document Type: Article

References (20)

1. Inzucchi SE, Bergenstal RM, Buse JB et al.; American Diabetes Association (ADA); European Association for the Study of Diabetes (EASD). Management of hyperglycemia in Type 2 diabetes: a patient-centered approach: positionstatement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 35(6), 1364-1379 (2012).
2. Bennett WL, Maruthur NM, Singh S et al. Comparative effectiveness and safety of medications for Type 2 diabetes: an update including new drugs and 2-drug combina tions. Ann. Intern. Med. 154(9), 602-613 (2011).
3. Nathan DM, Buse JB, Davidson MB et al.; American Diabetes Association; European Association for Study of Diabetes. Medical management of hyperglycemia in Type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 32(1), 193-203 (2009).
4. Akkati S, Sam KG, Tungha G. Emergence of promising therapies in diabetes mellitus. J. Clin. Pharmacol. 51(6), 796-804 (2011).
5. Rauseo A, Pacilli A, Palena A, De Cosmo SA. Management of Type 2 diabetes in geriatric patients. J. Nephrol. 23(Suppl. 15), S72-S79 (2010).
6. Dominguez LJ, Paolisso G, Barbagallo M. Glucose control in the older patient: from intensive, to effective and safe. Aging Clin. Exp. Res. 22(4), 274-280 (2010).
7. Struijs JN, Baan CA, Schellevis FG, Westert GP, van den Bos GA. Comorbidity in patients with diabetes mellitus: impact on medical health care utilization. BMC Health Serv. Res. 6, 84 (2006).
8. Chiu KC, Lee NP, Cohan P, Chuang LM. Beta cell function declines with age in glucose tolerant Caucasians. Clin. Endocrinol. (Oxf) 53(5), 569-575 (2000).
9. UK Prospective Diabetes Study Group. UK prospective diabetes study 16. Overview of 6 years' therapy of Type II diabetes: a progressive disease. Diabetes 44(11), 1249-1258 (1995).
10. Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes preva lence. Popul. Health Metr. 8, 29 (2010).
11. Cheung BM, Ong KL, Cherny SS, Sham PC, Tso AW, Lam KS. Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006. Am. J. Med. 122(5), 443-453 (2009).
12. Young BA, Lin E, Von Korff M et al. Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization. Am. J. Manag. Care 14(1), 15-23 (2008).
13. Hoerger TJ, Segel JE, Gregg EW, Saaddine JB. Is glycemic control improving in US adults? Diabetes Care 31(1), 81-86 (2008).
14. American Diabetes Association. Standards of medical care in diabetes-2012. Diabetes Care 35(Suppl. 1), S11-S63 (2012).
15. Sood A, Aron DC. Glycemic control in older adults: applying recent evidence to clinical practice. Geriatr. Aging 12(3), 130-134 (2009).
16. Brown AF, Mangione CM, Saliba D, Sarkisian CA; California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes. Guidelines for improving the care of the older person with diabetes mellitus. J. Am. Geriatr. Soc. 51(Suppl. 5 Guidelines), S265-S280 (2003).
17. Boothroyd RI, Fisher EB. Peers for progress: promoting peer support for health around the world. Fam. Pract. 27(Suppl. 1), i62-i68 (2010).
18. Shaya FT, Yan X, Farshid M et al. Social networks in cardiovascular disease management. Expert Rev. Pharmacoecon. Outcomes Res. 10(6), 701-705 (2010).
19. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27(5), 1047-1053 (2004).
20. Ong KL, Cheung BM, Wong LY, Wat NM, Tan KC, Lam KS. Prevalence, treatment, and control of diagnosed diabetes in the US National Health and Nutrition Examination Survey 1999-2004. Ann. Epidemiol. 18(3), 222-229 (2008).